HTB homepage • Conference reports • Articles by subject • Subscribe May 2011 Contents Editorial Volume 13 Number 5/6 May/June 2011 Conference reports First Workshop on Nanomedicine for Infectious Diseases of Poverty, 27-31 March 2011, Magaliesberg, South Africa 17th Annual Conference of the British HIV Association (BHIVA), 6-8 April 2011, Bournemouth Atazanavir in pregnancy: 155 cases in London clinics Co-morbidity and late presentation – findings from an over 50s cohort Health outcomes for young adults with perinatally acquired HIV infection following transfer to adult services The use of calcaneal stiffness index to screen for osteoporosis in HIV-infected individuals Frequency and characteristics of long-term non-progressors and HIV controllers in the Chelsea and Westminster cohort Cerebral function in perinatally HIV infected young people and HIV uninfected sibling controls An audit of HIV care provision for Immigration Removal Centre patients 12th International Workshop on Clinical Pharmacology of HIV Therapy, 13-15 April 2011, Miami Quad reduces levels of oral contraceptives Elvitegravir/cobicistat and acid reducing agents Lopinavir/r reduces levels of rifabutin Cobicistat has little impact on CYP2D6 and CYP2B6 Atazanavir levels indicate need for higher dose during pregnancy Etravirine lowers levels of maraviroc given at 300 or 600 mg twice daily Once-daily 150-mg maraviroc explored in people taking atazanavir/ritonavir Lopinavir troughs lower in children on once-daily dose with efavirenz Dose optimisation: 50 mg ritonavir-boosting, 3TC dosing and raltegravir once-daily 46th European Association for the Study of the Liver (EASL), 30 March-3 April 2011, Berlin, Germany Rapid report: state of HCV policy, treatment, access 18th Conference on Retroviruses and Opportunistic Infections (CROI), 27 February-3 March 2011, Boston When to start ART in patients co-infected with TB: results from two trials presented at CROI Inflammation and intervention: how does HIV cause AIDS and how does it cause disease despite ART PK and drug interactions Meeting report from 12th Pharmacology Workshop, Miami Meeting report from 18th CROI, Boston Atazanavir/ritonavir and combined oral contraceptives Side effects Tenofovir associated with fewer side-effect related switches compared to AZT or d4T in first-line treatment HIV prevention and transmission FEM-PrEP prevention study using daily Truvada halted during enrolment: interim analysis shows similar infection rates in active and placebo arms Basic science and immunology Reduced HIV replication in CD4 T cells from elite controllers More studies on the loss of naive T cells The immunological effects of old age and anti-CMV immunity in HIV infection BHIVA news BASHH/BHIVA PEPSE guidelines for comment (2011) UK national guideline on safer sex advice Other news Job vacancy: Treatment activist post at i-Base On the web Community resources and publications PDFs Volume 12 Number 5/6 May/June 2011 PDF HTB homepage • Conference reports • Articles by subject • Subscribe